GT Biopharma, Inc.
Headquarters Beverly Hills, CA
Financials
Prospectuses and Registrations
FORMNAMEDATE FILED
424B3Prospectus7/3/2025S-1/AGeneral form for registration of securities under the Securities Act of 19336/27/2025S-1General form for registration of securities under the Securities Act of 19336/11/2025424B3Prospectus3/14/2025S-3Registration statement under Securities Act of 19333/6/2025RWRegistration Withdrawal Request2/24/2025S-1/AGeneral form for registration of securities under the Securities Act of 19332/7/2025
Proxies
FORMNAMEDATE FILED
DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material6/11/2025DEF 14AOther definitive proxy statements6/11/2025PRE 14AOther preliminary proxy statements5/30/2025DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material6/17/2024DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material4/29/2024DEF 14AOther definitive proxy statements4/29/2024DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material11/6/2023
News
FORMNAMEDATE FILED
8-KNews Release9/26/20258-KFinancial Statements and Exhibits9/23/20258-KFinancial Statements and Exhibits8/29/20258-KSubmission of Matters to a Vote of Security Holders7/24/20258-KEntry into a Material Definitive Agreement6/11/20258-KEntry into a Material Definitive Agreement5/27/20258-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers5/13/2025
Ownership